XTL BIOPHARMACEUTICALS-ADR (XTLB) Stock Balance Sheet
NASDAQ:XTLB - Nasdaq - US98386D3070 - ADR - Currency: USD
| MRQ (2019-6-30) | 2018 (2018-12-31) | 2017 (2017-12-31) | 2016 (2016-12-31) | 2015 (2015-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 4.76M | 3.26M | 3.29M | 2.02M | 3.82M | |||
| Marketable Securities | N/A | 4.87M | 2.81M | 410.00K | 250.00K | |||
| Receivables | N/A | N/A | 110.00K | 320.00K | 200.00K | |||
| Other Current Assets | 4.41M | 70.00K | N/A | N/A | 0.00 | |||
| Total Current Assets | 9.17M | 8.20M | 6.21M | 2.75M | 4.27M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | 0.00 | 10.00K | 10.00K | |||
| Intangibles | N/A | 380.00K | 380.00K | 250.00K | 1.04M | |||
| Other Non-Current Assets | 380.00K | N/A | N/A | 0.00 | 10.00K | |||
| Total Non-Current Assets | 380.00K | 380.00K | 380.00K | 270.00K | 1.05M | |||
| TOTAL ASSETS | 9.55M | 8.58M | 6.59M | 3.02M | 5.32M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accounts Payable | N/A | 250.00K | 300.00K | 330.00K | 440.00K | |||
| Other Current Liabilities | 200.00K | N/A | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 200.00K | 250.00K | 300.00K | 330.00K | 440.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | 0.00 | 2.67M | N/A | N/A | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 2.67M | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 200.00K | 250.00K | 2.97M | 330.00K | 440.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | N/A | -152.59M | -155.65M | -154.90M | -152.49M | |||
| Additional Paid In Capital | N/A | 147.71M | 146.02M | 150.78M | 150.75M | |||
| Minority Interest | N/A | N/A | N/A | N/A | 0.00 | |||
| Common Shares | N/A | 13.18M | 13.18M | 6.62M | 6.61M | |||
| Treasury Stock | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Shareholders' Equity | 9.35M | 20.00K | 70.00K | 180.00K | 20.00K | |||
| Shares Outstanding | 514.20K | 514.20K | 514.20K | 274.20K | 547.10K | |||
| Tangible Book Value per Share | 0.18 | 0.15 | 0.06 | 0.09 | 0.07 | |||
| Total Shareholders' Equity | 9.35M | 8.32M | 3.62M | 2.69M | 4.89M | |||
| TOTAL LIABILITIES AND EQUITY | 9.55M | 8.58M | 6.59M | 3.02M | 5.32M | |||
| Statistics | ||||||||
| Current Ratio | 45.85 | 32.80 | 20.70 | 8.33 | 9.70 | |||
| Return On Assets (ROA) | 32.46% | 34.85% | -11.84% | -84.44% | -81.02% | |||
| Return On Equity (ROE) | 33.16% | 35.94% | -21.55% | -94.80% | -88.14% | |||
All data in USD , ROIC based on taxRate of 0.25